Myomo(MYO) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Myomo Reports Record Third Quarter Financial and Operating Results $9.2 million in revenue, raises full-year revenue guidance 225 MyoPro® authorizations and orders with 316 patients in backlog at quarter end 645 additions to the pipeline result in 1,263 patients in the pipeline as of September 30, 2024 BOSTON (November 6, 2024) – Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurologi ...